| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| OCs | Oral Contraceptives |
|---|---|
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
| CSL | cardiolipin synthetic lecithin; corticosteroid liposome |
| HSR | Harleco synthetic resin; heated serum reagin; homogeneously staining region |
| poly-IC, | poly-I:C copolymer of polyinosinic and polycytidylic acids; synthetic RNA polymer |
| OCA | Oral contraceptives agents |
|---|---|
| FSR | fractional synthetic rate |
| S | Synthetic |
| SOF | Synthetic Oviduct Fluid |
| SSI | Synthetic Sentence Identification |
naso-oral
| contraceptives, oral, synthetic | Oral contraceptives which owe their effectiveness to synthetic preparations. (12 Dec 1998) |
|---|
| contraceptives, postcoital, synthetic | Postcoital contraceptives which owe their effectiveness to synthetic preparations. (12 Dec 1998) |
|---|---|
| contraceptives, oral | Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally oestrogen or progesterone or both. (12 Dec 1998) |
| contraceptives, oral, combined | Fixed drug combinations administered orally for contraceptive purposes. (12 Dec 1998) |
| contraceptives, oral, hormonal | Oral contraceptives which owe their effectiveness to hormonal preparations. (12 Dec 1998) |
| contraceptives, oral, sequential | Drugs administered orally and sequentially for contraceptive purposes. (12 Dec 1998) |
| contraceptives, postcoital | Contraceptive substances to be used after coitus. Usually high doses of oestrogen are administered within 24-36 hours after coitus as an emergency measure, not as a replacement for the usual methods of contraception because of the side effects of high concentration of oestrogen. (12 Dec 1998) |
| contraceptives, postcoital, hormonal | Postcoital contraceptives which owe their effectiveness to hormonal preparations. (12 Dec 1998) |
| androgens, synthetic | Compounds obtained by chemical synthesis which possess masculinizing activities, but differ in structure from naturally occurring androgens. (12 Dec 1998) |
| vaccines, synthetic | Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. (12 Dec 1998) |
| genes, synthetic | Biologically functional sequences of DNA chemically synthesised in vitro. (12 Dec 1998) |
| glucocorticoids, synthetic | <chemical> Synthetic chemical compounds which increase gluconeogenesis, raising the concentration of liver glycogen and blood sugar, but differ in structure from naturally occurring glucocorticoids. Pharmacological action: steroidal anti-inflammatory agents, topical anti-inflammatory agents. (12 Dec 1998) |
| resins, synthetic | Polymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components. (12 Dec 1998) |
| mineralocorticoids, synthetic | Synthetic steroids that mimic the activity of the mineralocorticoids obtained from the adrenal cortex, but differ in structure from the naturally occurring mineralocorticoids. (12 Dec 1998) |
| progestational hormones, synthetic | Compounds obtained by chemical synthesis that possess progestational activity, but differ in structure from naturally occurring progestational hormones. (12 Dec 1998) |
| prostaglandin endoperoxides, synthetic | Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. (12 Dec 1998) |
Synonyms :
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|